Large-scale plasma proteomics uncovers preclinical molecular signatures of Parkinson's disease and overlap with other neurodegenerative disorders.
Homann J, Smith AG, Morgan S, Frick EA, Liu F, Viallon V, Maurya R, Korologou-Linden R, Dobricic V, Ohlei O, Deecke L, Hajizadah F, Zhao Y, Artaud F, Smith-Byrne K, Kolijn PM, Huerta JM, Winter N, Guevara M, Jimenez-Zabala A, Sánchez MJ, Trobajo-Sanmartín C, Cabrera-Castro N, Vinagre A, Petrova D, Sieri S, Key TJ, Wareham N, Kaaks R, Travis RC, Hahn T, Baker S, Kelly SM, Vermeulen R, Peters S, Masala G, Sacerdote C, Finkel N; Global Neurodegeneration Proteomics Consortium (GNPC); Elbaz A, Hess M, Katzke V, Bertram L, Gudnason V, Robinson O, Chen H, Middleton L, Winchester LM, Tzoulaki I, Gudmundsdottir V, Walker KA, Ferrari P, Riboli E, Gunter MJ, Lill CM.
Homann J, et al. Among authors: cabrera castro n.
medRxiv [Preprint]. 2025 Jul 30:2025.07.30.25332433. doi: 10.1101/2025.07.30.25332433.
medRxiv. 2025.
PMID: 40766128
Free PMC article.
Preprint.